The bill amends Chapter 5-19.1 of the General Laws regarding pharmacies by introducing a new section, 5-19.1-37, which allows pharmacists to dispense a one-time refill of certain medications for the continuation of therapy under specific conditions. This provision applies when a pharmacist is unable to obtain refill authorization from the prescriber or when the patient does not have a prescriber. The refill can be for up to 100 days of the prescribed medication, provided that the medication is not classified as a Schedule II-V controlled substance, is essential for maintaining life or managing a chronic condition, and that the pharmacist believes that interrupting therapy could lead to undesirable health consequences or cause physical or mental discomfort. Additionally, the dispensing pharmacist must notify the prescriber of the refill within seven business days, or document the absence of a prescriber if applicable.

This act is set to take effect on July 1, 2025.